Data as of Nov 21
| -0.29 / -0.30%|
The 26 analysts offering 12-month price forecasts for Novartis AG have a median target of 96.44, with a high estimate of 109.61 and a low estimate of 79.53. The median estimate represents a +1.53% increase from the last price of 94.98.
The current consensus among 29 polled investment analysts is to Buy stock in Novartis AG. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.